Skip to main content
. 2005 Feb 2;113(5):517–520. doi: 10.1289/ehp.6925

Table 1.

Distribution of subjects in the cohort by age at first test, sex, duration of follow-up, cancer frequency, and frequency of CAs.

Median (25th–75th percentiles)
Occupational exposure No. of subjects Mean age at first test (years) Sex (% males) Mean years since test Cancer cases (%) CAs CTAs CSAs
Ionizing radiation 676 40.3 70.4 11.6 57 (8.4) 2.5 (1.5–4.0) 2.0 (1.0–3.0) 1.0 (0.0–2.0)
Cytostatic drugs 2,150 36.5 12.8 7.4 61 (2.8) 2.0 (1.0–3.0) 1.3 (1.0–2.0) 0.0 (0.0–1.0)
Polyclic aromatic hydrocarbons 2,241 39.4 86.1 10.1 108 (4.8) 2.0 (1.0–3.5) 1.5 (1.0–2.4) 1.0 (0.0–1.0)
Aromatic amines 851 40.3 57.8 9.0 28 (3.3) 2.0 (1.3–3.0) 1.8 (1.0–3.0) 0.6 (0.0–1.0)
Other exposures 4,031 38.0 58.7 10.7 170 (4.2) 2.0 (1.0–3.0) 1.0 (1.0–2.0) 0.5 (0.0–1.0)
Nonexposed 1,913 36.2 55.2 8.8 61 (3.2) 2.0 (1.0–3.0) 1.0 (0.5–2.0) 0.0 (0.0–1.0)
Total cohort 11,862 38.0 55.6 9.6 485 (4.1) 2.0 (1.0–3.0) 1.0 (1.0–2.0) 0.5 (0.0–1.0)